Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675865 · ClinicalTrials.gov registry record · NA
Cryoablation for Monomorphic Ventricular Tachycardia
A NA study of Sustained VT, sponsored by Adagio Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 206
- Enrollment target
- 15
- Study locations
NCT05675865: Recruiting NA study of Sustained VT, sponsored by Adagio Medical.
NCT05675865 is a NA study of Sustained VT that is actively recruiting participants, run by Adagio Medical. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 15 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675865, a NA study of Sustained VT, is actively recruiting participants, sponsored by Adagio Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
Primary Outcome
Events will be adjudicated by an independent Clinical Events Committee (CEC). MAEs include any of the following: * Death * Acute myocardial infarction * Cardiac perforation/pericardial tamponade * Cerebral infarct or systemic embolism * Major bleeding requiring transfusion * Acute Mitral, Tricuspid or Aortic valve damage resulting in moderate or severe regurgitation * Access site complications requiring medical or surgical intervention * Pericarditis * Heart block requiring a permanent pacemake
Conditions Studied
Interventions
- DEVICE cryoablation procedure
Study Locations (15)
New York
- Icahn School of Medicine at Mount Sinai - New York
- Weill Cornell Medical Center - New York
- Northwell Health- Staten Island University Hospital - Staten Island
Quebec
- Montreal Heart Institute - Montreal
- McGill University - Montreal
Arizona
- Banner University Medical Center Phoenix - Phoenix
California
- University of California San Francisco - San Francisco
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT05675865 shows while recruiting
NCT05675865 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Sustained VT appearing as the primary indexed condition, and to 1 intervention - of which cryoablation procedure is the first listed.
NCT05675865 lists 15 locations in 12 states (New York, Quebec, Arizona).
Frequently Asked Questions
What is clinical trial NCT05675865 about?
NCT05675865 is a clinical study titled "Cryoablation for Monomorphic Ventricular Tachycardia". The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
What is the current status of trial NCT05675865?
This trial is currently recruiting. It is a NA study. The enrollment target is 206 participants. The study started on 2023-09-11. Estimated completion is 2026-03-30.
What conditions does trial NCT05675865 study?
This clinical trial studies the following conditions: Sustained VT.
What interventions are being tested in trial NCT05675865?
The interventions under investigation include: cryoablation procedure (DEVICE).
Who is sponsoring clinical trial NCT05675865?
This trial is sponsored by Adagio Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675865 being conducted?
This trial has 15 study locations across Arizona, California, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sustained VT
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05675865's enrollment target sits among peer trials
206 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI